Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Abroad (travel likely)Recruiting
Conditions
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy · Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy · Wild-Type Transthyretin Cardiac Amyloidosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Trial Site, Paris, France
Clinical Trial Site, Auckland, New Zealand
Clinical Trial Site, Umeå, Sweden
Clinical Trial Site, London, United Kingdom